Perceptions on Management of Atopic Dermatitis in Children Under 2 Years by Community Pediatricians: A Focus Group Study

Clin Pediatr (Phila). 2023 Oct;62(10):1176-1185. doi: 10.1177/00099228231154132. Epub 2023 Feb 16.

Abstract

Atopic dermatitis (AD) is a common skin condition and is undertreated in children under 2 years, whom there are no specific guidelines for. We sought to understand barriers to AD treatment and primary care pediatricians' (PCPs) suggested solutions. We conducted semi-structured focus groups (n = 5) with PCPs (n = 17) on how the undertreatment of AD can be addressed. Data were analyzed using an inductive qualitative approach. Participants noted that the perceived undertreatment of AD in children under 2 years could be explained by topical corticosteroid (TCS) use hesitancy, lack of caregiver adherence to PCP recommendations, and under-documentation of AD in the electronic medical record (EMR). Proposed suggestions for improving AD management included caregiver and PCP education on TCS safety; stepwise management guidelines for this age group; and EMR aids to help document and manage AD. Research is warranted to create and disseminate clinician-friendly AD management guidelines for this age group.

Keywords: atopic dermatitis; eczema; focus groups; physicians’ practice patterns; primary health care.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Cortex Hormones
  • Child
  • Dermatitis, Atopic* / drug therapy
  • Focus Groups
  • Glucocorticoids
  • Humans
  • Infant
  • Pediatricians

Substances

  • Adrenal Cortex Hormones
  • Glucocorticoids